{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:23:23Z","timestamp":1786116203768,"version":"build-2736575974"},"reference-count":91,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Infection"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">Pneumocystis jirovecii<\/jats:italic>\n                      pneumonia (PJP) in non-HIV immunocompromised adults carries 30%\u201360% mortality. Adjunctive corticosteroids are standard in HIV-PJP but remain contested in non-HIV PJP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To determine whether adjunctive corticosteroids reduce mortality and invasive mechanical ventilation (IMV) in non-HIV PJP, and whether effect estimates differ between randomized and observational study designs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Systematic review and meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources and methods:<\/jats:title>\n                    <jats:p>\n                      Six databases and two trial registers were searched from inception to February 7, 2026. Randomized and observational studies comparing adjunctive corticosteroids versus no corticosteroids or placebo in non-HIV adults with PJP were eligible. Random-effects meta-analyses (restricted maximum likelihood) of two co-primary outcomes included subgroup, sensitivity,\n                      <jats:italic toggle=\"yes\">E<\/jats:italic>\n                      -value, and Grading of Recommendations Assessment analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-eight studies were included (one randomized controlled trial (RCT), 27 observational;\n                      <jats:inline-formula>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" display=\"inline\" overflow=\"scroll\">\n                          <mml:mrow>\n                            <mml:mi>\u223c<\/mml:mi>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:inline-formula>\n                      5300 patients): 22 contributed corticosteroid-versus-no-corticosteroid comparisons and six contributed dose-comparison data only. Evidence was discordant by design (interaction\n                      <jats:inline-formula>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" display=\"inline\" overflow=\"scroll\">\n                          <mml:mrow>\n                            <mml:mi>p<\/mml:mi>\n                            <mml:mo>=<\/mml:mo>\n                            <mml:mn>0<\/mml:mn>\n                            <mml:mo>.<\/mml:mo>\n                            <mml:mn>006<\/mml:mn>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:inline-formula>\n                      ): the RCT showed lower IMV (hazard ratio (HR) 0.36, 95% CI 0.14\u20130.90) and lower 90-day mortality (HR 0.59, 0.37\u20130.93); regression-adjusted observational studies suggested harm (odds ratio (OR) 1.56, 1.10\u20132.22); propensity-based estimates were null-compatible. Pre-specified mortality pools were non-significant short-term (OR 1.22, 0.88\u20131.70) and intermediate-term (OR 1.39, 0.85\u20132.29). Secondary infections (\n                      <jats:inline-formula>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\" display=\"inline\" overflow=\"scroll\">\n                          <mml:mrow>\n                            <mml:mi>k<\/mml:mi>\n                            <mml:mo>=<\/mml:mo>\n                            <mml:mn>4<\/mml:mn>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:inline-formula>\n                      ): OR 1.04 (0.63\u20131.72); RCT 0.59 (0.32\u20131.06).\n                      <jats:italic toggle=\"yes\">E<\/jats:italic>\n                      -values for RCT effects (3.44 IMV; 2.24 mortality) exceeded the 1.81\n                      <jats:italic toggle=\"yes\">E<\/jats:italic>\n                      -value of the adjusted observational mortality pool. Certainty was very low for pooled mortality and moderate for RCT outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Reliable inference rests on the single RCT rather than the pooled observational estimate, which is discordant by design and most consistent with confounding by indication. In the RCT, corticosteroids did not significantly reduce 28-day mortality but lowered IMV and 90-day mortality and sped respiratory recovery, without clear excess secondary infections (low certainty). Corticosteroids may be considered for severe respiratory failure using the PIC (ClinicalTrials.gov NCT02944045) protocol; adequately powered confirmatory trials are needed.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Trial registration<\/jats:italic>\n                        :\n                      <\/jats:bold>\n                      PROSPERO CRD420261304396.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20499361261468451","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T09:40:59Z","timestamp":1785836459000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjunctive corticosteroids in non-HIV immunocompromised patients with\n                    <i>Pneumocystis jirovecii<\/i>\n                    pneumonia: a systematic review and meta-analysis"],"prefix":"10.1177","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8275-8004","authenticated-orcid":false,"given":"Gustavo","family":"Rosales-Chavez","sequence":"first","affiliation":[{"name":"Nuevo Hospital Civil de Guadalajara \u201cDr. Juan I. Menchaca,\u201d Guadalajara, Jalisco, Mexico"},{"name":"Divisi\u00f3n Salud, Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Z\u00fa\u00f1iga, Jalisco, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0505-6340","authenticated-orcid":false,"given":"Pedro","family":"Mart\u00ednez-Ayala","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n Salud, Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Z\u00fa\u00f1iga, Jalisco, Mexico"},{"name":"Antiguo Hospital Civil de Guadalajara \u201cFray Antonio Alcalde,\u201d Guadalajara, Jalisco, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0798-7384","authenticated-orcid":false,"given":"Mauricio Alfredo","family":"Ambriz-Alarc\u00f3n","sequence":"additional","affiliation":[{"name":"Antiguo Hospital Civil de Guadalajara \u201cFray Antonio Alcalde,\u201d Guadalajara, Jalisco, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2891-924X","authenticated-orcid":false,"given":"Brian Rafael","family":"Rubio-Mora","sequence":"additional","affiliation":[{"name":"Antiguo Hospital Civil de Guadalajara \u201cFray Antonio Alcalde,\u201d Guadalajara, Jalisco, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0251-6425","authenticated-orcid":false,"given":"Judith Carolina De","family":"Arcos-Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Hospital Civil de Oriente, Tonal\u00e1, Jalisco, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5871-4179","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"L\u00f3pez-Y\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"Divisi\u00f3n Salud, Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Z\u00fa\u00f1iga, Jalisco, Mexico"},{"name":"Hospital Civil de Oriente, Tonal\u00e1, Jalisco, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-2808","authenticated-orcid":false,"given":"Alejandro","family":"Mar\u00edn-Casta\u00f1eda-Bar\u00f3n","sequence":"additional","affiliation":[{"name":"Hospitales Puerta de Hierro Colima, Colima, Colima, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4233-3271","authenticated-orcid":false,"given":"Andr\u00e9s Alejandro","family":"Brise\u00f1o-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Centro Respiratorio de Occidente, Guadalajara, Jalisco, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6135-4270","authenticated-orcid":false,"given":"Jos\u00e9 Rafael","family":"Villaf\u00e1n-Bernal","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmunogen\u00f3mica y Enfermedades Metab\u00f3licas, Instituto Nacional de Medicina Gen\u00f3mica, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4867-1359","authenticated-orcid":false,"given":"Jaime Alejandro","family":"S\u00e1nchez-Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Cl\u00ednica de Neumolog\u00eda y Medicina Pleural, Guadalajara, Jalisco, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1901-392X","authenticated-orcid":false,"given":"Jaime","family":"Briseno-Ramirez","sequence":"additional","affiliation":[{"name":"Hospital Civil de Oriente, Tonal\u00e1, Jalisco 45425, Mexico Divisi\u00f3n Salud, Centro Universitario de Tlajomulco, Universidad de Guadalajara, Tlajomulco de Z\u00fa\u00f1iga, Jalisco 45641, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032588"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof9080812"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-012-0453-0"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2023.02.014"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100400"},{"key":"e_1_3_4_7_2","volume-title":"WHO fungal priority pathogens list to guide research, development and public health action","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. Geneva: WHO, 2022."},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.07.010"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-0477"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.09.116"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1621"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.3.712"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12651"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119384"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00939-16"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2009-0367OC"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/140.5.1204"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000487713"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI6688"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2712"},{"key":"e_1_3_4_21_2","article-title":"Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit","volume":"8","author":"Gharamti AA","year":"2021","unstructured":"Gharamti AA, Mundo W, Chastain DB, et al. Pneumocystis jirovecii pneumonia: a proposed novel model of corticosteroid benefit. Ther Adv Infect Dis 2021; 8: 20499361211032034.","journal-title":"Ther Adv Infect Dis"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.104.3.751"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2009.131668"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1805"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw158"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04608-1"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.680108"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011223232104"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011223232103"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199011223232131"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006150.pub2"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3390\/jof7080625"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.arbres.2016.06.016"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-00649-9"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.12.001"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250611"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2018.04.026"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009758"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1999.tb01603.x"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-223504"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.11.003"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00125-0"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00197-3"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2607"},{"key":"e_1_3_4_45_2","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71.","journal-title":"BMJ"},{"key":"e_1_3_4_46_2","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024)","author":"Higgins JPT","year":"2024","unstructured":"Higgins JPT, Thomas J, Chandler J, et al. (eds). Cochrane handbook for systematic reviews of interventions version 6.5 (updated August 2024). Cochrane, 2024."},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-1-2"},{"key":"e_1_3_4_49_2","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JAC","year":"2019","unstructured":"Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019; 366: l4898.","journal-title":"BMJ"},{"key":"e_1_3_4_50_2","volume-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells GA","year":"2011","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute, 2011."},{"key":"e_1_3_4_51_2","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel N","year":"1959","unstructured":"Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719\u2013748.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1761"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1164"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-87"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1086\/598651"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.2307\/3001666"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010247"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1230"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2025.10.036"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn065"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa354"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.113.5.1215"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S493298"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-2025-1984"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.010"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.6.676"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0006-341X.2000.00455.x"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000864"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1136\/ebmental-2019-300117"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i03"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03419.x"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(03)00038-0"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0223"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-76"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00669-11"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2014.03.003"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1855-x"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S199761"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-020-04118-w"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab460"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07489-2"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-025-00187-7"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-27907-9"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.07.070"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10151-3"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292507"}],"container-title":["Therapeutic Advances in Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20499361261468451","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20499361261468451","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20499361261468451","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T08:16:31Z","timestamp":1786004191000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20499361261468451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":91,"alternative-id":["10.1177\/20499361261468451"],"URL":"https:\/\/doi.org\/10.1177\/20499361261468451","relation":{},"ISSN":["2049-9361","2049-937X"],"issn-type":[{"value":"2049-9361","type":"print"},{"value":"2049-937X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]},"article-number":"20499361261468451"}}